Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bartoli

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Journal of Immunological Methods|March 4, 2000
"Affinity maturation" of ligands for HCV-specific serum antibodiesL Urbanelli, P Fortugno, F Bartoli, et al.
Biochimica Et Biophysica Acta|October 31, 1998
Expression of biological activity of draculin, the anticoagulant factor from vampire bat saliva, is strictly dependent on the appropriate glycosylation of the native moleculeA Z Fernandez, A Tablante, F Bartoli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 1, 1990
[Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides, glutathione peroxidase activity and serological screening for syphilis and HIV in immigrants from developing countries]S Passi, A Morrone, M Picardo, et al.
Thrombosis and Haemostasis|January 1, 1995
Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus)R Apitz-Castro, S Béguin, A Tablante, et al.
Gut|June 13, 2006
Glucocorticoid receptor polymorphisms in inflammatory bowel diseaseG Decorti, S De Iudicibus, G Stocco, et al.
Biochimica Et Biophysica Acta|September 24, 1991
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoeneR Apitz-Castro, M K Jain, F Bartoli, et al.
Scientific Reports|January 31, 2019
Suppression of SIRT1 in Diabetic Conditions Induces Osteogenic Differentiation of Human Vascular Smooth Muscle Cells via RUNX2 SignallingF Bartoli-Leonard, F L Wilkinson, A Schiro, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 1, 1990
Intestinal ischemia: morphological features--IS Santacroce, G Nicolardi, E Sinigaglia, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1979
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterizationW Marconi, F Bartoli, E Mantovani, et al.
The Journal of Biological Chemistry|June 3, 1994
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human plateletsF Bartoli, H K Lin, F Ghomashchi, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Journal of Immunological Methods|March 4, 2000
"Affinity maturation" of ligands for HCV-specific serum antibodiesL Urbanelli, P Fortugno, F Bartoli, et al.
Biochimica Et Biophysica Acta|October 31, 1998
Expression of biological activity of draculin, the anticoagulant factor from vampire bat saliva, is strictly dependent on the appropriate glycosylation of the native moleculeA Z Fernandez, A Tablante, F Bartoli, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|November 1, 1990
[Blood levels of vitamin E, polyunsaturated fatty acids of phospholipids, lipoperoxides, glutathione peroxidase activity and serological screening for syphilis and HIV in immigrants from developing countries]S Passi, A Morrone, M Picardo, et al.
Thrombosis and Haemostasis|January 1, 1995
Purification and partial characterization of draculin, the anticoagulant factor present in the saliva of vampire bats (Desmodus rotundus)R Apitz-Castro, S Béguin, A Tablante, et al.
Gut|June 13, 2006
Glucocorticoid receptor polymorphisms in inflammatory bowel diseaseG Decorti, S De Iudicibus, G Stocco, et al.
Biochimica Et Biophysica Acta|September 24, 1991
Evidence for direct coupling of primary agonist-receptor interaction to the exposure of functional IIb-IIIa complexes in human blood platelets. Results from studies with the antiplatelet compound ajoeneR Apitz-Castro, M K Jain, F Bartoli, et al.
Scientific Reports|January 31, 2019
Suppression of SIRT1 in Diabetic Conditions Induces Osteogenic Differentiation of Human Vascular Smooth Muscle Cells via RUNX2 SignallingF Bartoli-Leonard, F L Wilkinson, A Schiro, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|August 1, 1990
Intestinal ischemia: morphological features--IS Santacroce, G Nicolardi, E Sinigaglia, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1979
Development of new antithrombogenic surfaces by employing platelet antiaggregating agents: preparation and characterizationW Marconi, F Bartoli, E Mantovani, et al.
The Journal of Biological Chemistry|June 3, 1994
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human plateletsF Bartoli, H K Lin, F Ghomashchi, et al.
Pageof 9